ABSTRACT
In October of 2001, a shipment of anti-tuberculosis (TB) drugs arrived in Chisinau, the Republic of Moldova, a country with one of the highest TB rates in Europe, chronic drug shortages, and, until some months earlier, no established DOTS program. The shipment, which had traveled from a manufacturer in Mumbai, India, through a supply chain that had never before been tested, was en route to local health facilities, where it would eventually save 5000 lives. Its successful distribution marked the beginning of a revolution in TB control.
